Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Gemin X Pharmaceuticals - Gemin X Initiates Phase 2 Clinical Study of Obatoclax in Combination with Standard Chemotherapy for First-Line Treatment of Small Cell Lung Cancer
Ovarian Cancer - Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
Bladder Cancer - Research on bladder cancer published by scientists at University of Naples
Breast Cancer - New findings in breast cancer described from Vall d'Hebron University
Clinical Trial Research - New clinical trial research study findings reported from Tohoku University
Colon Cancer - Research from P. Kozuch et al has provided new information about colon cancer
Drug Development - Research in the area of drug development reported from X.F. Huang and colleagues
Glioblastoma - Researchers' work from University of California focuses on glioblastoma
Kidney Transplants - New kidney transplants study findings recently were reported by researchers at Erasmus University
Malaria Vaccines - Research from University of Oxford has provided new data on malaria vaccines
Multiple Sclerosis - Study data from G. Giovannoni et al provide new insights into multiple sclerosis
Myeloma - New data from Mayo Clinic illuminate research in myeloma
Myeloma - Recent studies from Loyola University Chicago add new data to myeloma
Myeloma - Research results from D.A. Stewart and colleagues update understanding of myeloma
Non-Hodgkin Lymphoma - Studies from Y.L. Kasamon and colleagues yield new information about non-hodgkin lymphoma
Non-Small Cell Lung Cancer - New data from University of Utah illuminate research in non-small cell lung cancer
Non-Small Cell Lung Cancer - Scientists at Rush University report research in non-small cell lung cancer
Small Cell Lung Cancer - Research from Washington University in small cell lung cancer provides new insights
Solid Cancer - Recent studies by J.J. Stephenson and co-authors add new data to solid cancer findings
Breast Cancer Clinical Trial - Study results from University Hospital in the area of breast cancer clinical trial published
Breast Cancer Therapy - Reports from Mayo Clinic, Division of Hematology-Oncology highlight recent research in breast cancer therapy
Esophagogastric Cancer Therapy - Reports on esophagogastric cancer therapy findings from Dana-Farber Cancer Institute, Department of Medical Oncology provide new insights
Functional Dyspepsia - Researchers from University Hospital, Department of Gastroenterology describe findings in functional dyspepsia
Gastric Cancer Therapy - Findings from University of Dresden, Department of Internal Medicine I in gastric cancer therapy reported
Immunotherapy - Research from M. Figini et al broadens understanding of immunotherapy
Mantle Cell Lymphoma Therapy - Researchers from University Medical Center detail new studies and findings in the area of mantle cell lymphoma therapy
Prostate Cancer Therapy - Reports outline prostate cancer therapy study findings from University of Maryland, Greenebaum Cancer Center
Prostate Cancer Therapy - Research in the area of prostate cancer therapy reported from European Institute of Oncology, Division of Medical Oncology
Rectal Cancer Therapy - New data from University of Modena illuminate research in rectal cancer therapy
Abraxis BioScience, Inc. - Abraxis BioScience Reports 2008 Fourth Quarter and Full-Year Financial Results
Achaogen - Achaogen Signs $26.6 Million Contract With NIAID for Development of New Therapy to Treat Resistant Strains of NIAID Category a and B Priority Pathogens
Acne Vulgaris - Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statis
Acorda Therapeutics, Inc. - Data Published in the Lancet Show Fampridine-SR Improved Walking Ability in People with Multiple Sclerosis
Alzheimer Disease - Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Advanced Non-Small Cell Lung Cancer
ArQule, Inc. - ArQule Expands Clinical Program With ARQ 197, c-Met Inhibitor
Asthma - Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
Bavarian Nordic A/S - Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE With the FDA After Successful End of Phase II Meeting
Cell Genesys, Inc. - Cell Genesys Announces Final Results from Phase 3 Program of GVAX Immunotherapy for Prostate Cancer
Celsion Corporation - Celsion Reports Fourth Quarter and Full Year 2008 Financial Results
Clinical Trial Research - Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company
CombinatoRx, Incorporated - CombinatoRx Reports Financial Results for the Fourth Quarter and Year End 2008
Constipation - Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
Cougar Biotechnology, Inc. - Cougar Biotechnology Announces Presentation of Positive CB7630 Abiraterone Acetate Phase II Data at ASCO 2009 Genitourinary Cancers Symposium
Depomed, Inc. - Depomed Completes Enrollment of Breeze 1 Phase 3 Clinical Trial for Non-Hormonal Treatment in Menopausal Hot Flashes
Depomed, Inc. - Depomed Reports Fourth Quarter and Year-End 2008 Financial Results
Drug Development - FDA Clears Cellectar's IND Application for Lead Drug Candidate
Drug Resistance - Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
Epilepsy - Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
Exelixis, Inc. - Exelixis Announces Fourth Quarter and Full Year 2008 Financial Results
FoldRx - FoldRx to Raise Awareness of TTR Amyloidosis in Conjunction with NORD’s Rare Diseases Day
GPC Biotech AG - Safety and Overall Survival Data in Docetaxel-Refractory Patients Enrolled in the Satraplatin SPARC Trial Being Presented at 2009 ASCO Genitourinary Cancers Symposium
Ikano Therapeutics Inc. - Intranasal Therapeutics Changes Name to Ikano Therapeutics and Completes Series B Financing
ThromboGenics Nv - ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema MIVI II DME
Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals Strengthens HCV Drug Development Portfolio, Adds Novel Polymerase Inhibitors to Shape New Combinations with Telaprevir
XenoPort, Inc. - Astellas and XenoPort Announce Positive Results from Phase 2 Trial of ASP8825/XP13512 in Japan for Restless Legs Syndrome
